Effects of VHL deficiency on endolymphatic duct and sac

Cancer Research

Volumn 65, Issue 23, 2005, Pages 10847-10853

  Gläsker, Sven ^a   Lonser, Russell R ^a   Tran, Maxine G B ^c   Ikejiri, Barbara ^a   Butman, John A ^b   Zeng, Weifen ^a   Maxwell, Patrick H ^c   Zhuang, Zhengping ^a   Oldfield, Edward H ^a   Vortmeyer, Alexander O ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VON HIPPEL LINDAU PROTEIN;

ALLELE; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; ENDOLYMPHATIC SAC; ENDOLYMPHATIC SAC TUMOR; GENE; GENE INACTIVATION; GENE MUTATION; GERM LINE; HUMAN; HUMAN TISSUE; KIDNEY PARENCHYMA; PRIORITY JOURNAL; PROTEIN DEFICIENCY; UNITED STATES; UPREGULATION; VESTIBULE AQUEDUCT; VHL GENE; VON HIPPEL LINDAU DISEASE;

EAR NEOPLASMS; ENDOLYMPHATIC DUCT; ENDOLYMPHATIC SAC; HIPPEL-LINDAU DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; PRECANCEROUS CONDITIONS; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 28244434856     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-1104     Document Type: Article

References (34)

1. Heffner DK. Low-grade adenocarcinoma of probable endolymphatic sac origin A clinicopathologic study of 20 cases. Cancer 1989;64:2292-302.
2. Manski TJ, Heffner DK, Glenn GM, et al. Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease. JAMA 1997;277:1461-6.
3. Tibbs RE, Jr., Bowles AP, Jr., Raila FA, Fratkin JD, Hutchins JB. Should endolymphatic sac tumors be considered part of the von Hippel-Lindau complex? Pathology case report. Neurosurgery 1997;40:848-55.
4. Kawahara N, Kume H, Ueki K, Mishima K, Sasaki T, Kirino T. VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease. Neurology 1999;53:208-10.
5. Choo D, Shotland L, Mastroianni M, et al. Endolymphatic sac tumors in von Hippel-Lindau disease. J Neurosurg 2004;100:480-7.
6. Vortmeyer AO, Huang SC, Koch CA, et al. Somatic von Hippel-Lindau gene mutations detected in sporadic endolymphatic sac tumors. Cancer Res 2000;60: 5963-5.
7. Hamazaki S, Yoshida M, Yao M, et al. Mutation of von Hippel-Lindau tumor suppressor gene in a sporadic endolymphatic sac tumor. Human Pathol 2001;32:1272-6.
8. Vortmeyer AO, Choo D, Pack SD, Oldfleld E, Zhuang Z. von Hippel-Lindau disease gene alterations associated with endolymphatic sac tumor. J Natl Cancer Inst 1997; 89:970-2.
9. Lonser RR, Kim HJ, Butman JA, Vortmeyer AO, Choo DI, Oldfield EH. Tumors of the endolymphatic sac in von Hippel-Lindau disease. N Engl J Med 2004;350: 2481-6.
10. +-ATPase in the human endolymphatic sac. Archives of Oto Rhino Laryngology 1988;245: 221-3.
11. ++ activity in the endolymphatic space. Archives Oto Rhino Laryngology 1986;243:141-2.
12. Morgenstern C, Amano H, Orsulakova A. Ion transport in the endolymphatic space. Am J Otolaryngol 1982;3:323-7.
13. Erwall C, Friberg U, Bagger-Sjoback D, Rask-Andersen H. Degradation of the homogeneous substance in the endolymphatic sac. Acta Otolaryngol 1988;105:209-17.
14. Rask-Andersen H, Stahle J. Immunodefence of the inner ear? Lymphocyte-macrophage interaction in the endolymphatic sac. Acta Otolaryngol 1980;89: 283-94.
15. Harris JP. Autoimmunity of the inner ear. Am J Otol 1989;10:193-5.
16. Li JC, Brackmann DE, Lo WW, Carberry JN, House JW. Reclassification of aggressive adenomatous mastoid neoplasms as endolymphatic sac tumors. Laryngoscope 1993;103;1342-8.
17. Price EB, Jr. Papillary cystadenoma of the epididymis. A clinicopathologic analysis of 20 cases. Arch Pathol Lab Med 1971;91:456-70.
18. Pollak A, Bohmer A, Spycher M, Fisch U. Are papillary adenomas endolymphatic sac tumors? Ann Otol Rhinol Laryngol 1995;104:613-9.
19. Bold EL, Wanamaker JR, Hughes GB, Rhee CK, Sebek BA, Kinney SE. Adenomatons lesions of the temporal bone immunohistochemical analysis and theories of histogenesis. Am J Otol 1995;16:146-52.
20. Vortmeyer AO, Yuan Q, Lee YS, Zhuang Z, Oldfield EH. Developmental effects of von Hippel-Lindau gene deficiency. Ann Neurol 2004;55:721-8.
21. Talks KL, Turley H, Gatter KC, et al. The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 2000;157: 411-21.
22. Pastorekova S, Zavadova Z, Kostal M, Babusikova O, Zavada J. A novel quasi-viral agent, MaTu. is a two-component system. Virology 1992;187:620-6.
23. Zhuang Z, Vortmeyer AO. Applications of tissue microdissection in cancer genetics. Cell Vision 1998;5: 43-8.
24. Lo WW, Daniels DL, Chakeres DW, et al. The endolymphatic duct and sac. Am J Neuroradiol 1997; 18:881-7.
25. Gordeuk VR, Sergueeva AI, Miasnikova GY, et al. Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors. Blood 2004;103:3924-32.
26. Kempermann G, Neumann HP, Volk B. Endolymphatic sac tumours. Histopathology 1998;33:2-10.
27. Pallanch JF, Weiland LH, McDonald TJ, Facer GW, Harner SG. Adenocarcinoma and adenoma of the middle ear. Laryngoscope 1982;92:47-54.
28. Netter FH, Colacino S. Atlas of human anatomy. Summit (MJ): Ciba Geigy Corp.; 1989.
29. Williams PL. Gray's anatomy. 38th ed. New York (NY): Churchill Livingstone; 1995.
30. Friberg U, Rask-Andersen H, Bagger-Sjoback D. Human endolymphatic duct. An ultrastructural study. Arch Otolaryngol 1984;110:421-8.
31. Arenberg IK, Rask-Andersen H, Wilbrand H, Stahle J. The surgical anatomy of the endolymphatic sac. Arch Otolaryngol 1977;103:1-11.
32. Mohr VH, Vortmeyer AO, Zhuang Z, et ul. Histopathology and molecular genetics of multiple cysts and microscopic (serous) adenomas of the pancreas in von Hippel-Lindau patients. Am J Pathol 2000;157:1615-21.
33. Gruber MB, Healey GB, Toguri AG, Warren MM. Papillary cystadenoma of epididymis: component of von Hippel-Lindau syndrome. Urology 1980;16:305-6.
34. Poe DS, Tarlov EC, Thomas CB, Kveton JF. Aggressive papillary tumors of temporal bone. Otolaryngol Head Neck Surg 1993;108:80-6.